Irreversible sensorineural hearing loss due to Imatinib

Leukemia Research

Volumn 32, Issue 6, 2008, Pages 991-992

  Attili, Venkata Satya Suresh ^a   Bapsy, P P ^a   Anupama, G ^a   Lokanatha, D ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

Chronic myeloid leukemia; Imatinib; Sensorineural deafness

Indexed keywords

DASATINIB; HYDROXYUREA; IMATINIB; INTERFERON;

ADULT; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG WITHDRAWAL; EVOKED RESPONSE AUDIOMETRY; HUMAN; MALE; MYELOID LEUKEMIA; PERCEPTION DEAFNESS; PRIORITY JOURNAL;

ADULT; HEARING LOSS, SENSORINEURAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRIMIDINES;

EID: 40849102454     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.11.039     Document Type: Article

References (5)

1. Druker B.J., Guilhot F., O'Brien S.G., Gathmann I., Kantarjian H., Gattermann N., et al. Five-year data on imatinib show best-ever survival with chronic myeloid leukemia. N Engl J Med 355 (2006) 2408-2417
2. Kerkela R., Grazette L., Yacobi R., Iliescu C., Patten R., Beahm C., et al. Cardiotoxicity of the cancer therapeutic agent Imatinib mesylate. Nat Med 12 (2006) 908-916
3. Govind Babu K., Attili V.S., Bapsy P.P., and Anupama G. Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia. Int Ophthalmol 27 1 (2007) 43-44
4. Grazette L.P., Kerkela R., and Patten R. Imatinib mesylate (Gleevec) induces mitochondrial dysfunction and caspase activation in cardiac myocytes. J Card Fail 11 Suppl. (2005) S126
5. Talpaz M., Shah N.P., Kantarjian H., Donato N., Nicoll J., Paquette R., et al. Dasatinib in Imatinib-resistant Philadelphia chromosome-positive leukemia. N Engl J Med 354 (2006) 2531-2541